Site map

LATEST NEWS

11.06.13 | SAROGLITAZAR – FIRST NCE DISCOVERED AND DEVELOPED IN INDIA TO REACH THE MARKET

Zydus Cadila announced on June 5 2013 the approval by the Drug Controller General of India (DCGI) of Saroglitazar (ZYH1), or Lipaglyn^TM. The drug has been approved for launch in India for the treatment of diabetic dyslipidemia or hypertriglyceridemia in patients with type II diabetes not controlled by statins alone.

25.02.13 | INNOVATIVE DRUG DISCOVERY IN INDIA – THE GROWING INDIAN R&D PIPELINE

Ranbaxy’s recently launched Synriam, together with Glenmark’s (and US partner Salix Pharmaceuticals’) approval of Crofelemer are only the two first visible signs of India’s growing presence in innovative drug discovery and development...

30.07.12 | BIOTECHNOLOGY IN INDIA – 2012 “BIOSPECTRUM-ABLE” SURVEY

According to the tenth annual Indian Biotech Industry survey by Biospectrum-ABLE (Association of Biotechnology Led Enterprises), the Indian biotech industry passed the 4 Billion US$ mark in 2011-12...

03.01.12 | INDIAN DRUG DISCOVERY PIPELINE

In the late nineteen eighties, Indian pharma companies started in-house drug discovery activities, aiming at developing the country’s first home-made drug ...

03.01.12 | PHARMA AND BIOTECHNOLOGY ACTIVITIES IN INDIA

The Indian biotech industry has been booming over the past decade, growing from 0.5 Billion US$ in 2002-03 to more than 3.75 Billion US$ in 2010-11, and counting more than seven hundred players. ...